NCT03967600 Clinical and Biological Characteristics of Hidradenitis Suppurativa
| NCT ID | NCT03967600 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Hidradenitis Suppurativa |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-07-15 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-07-15 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Eligibility Criteria
Hidradenitis Suppurativa Patients Inclusion Criteria: 1. Age 13 years or older 2. Diagnosis of HS clinically-confirmed by a physician Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent. Healthy Volunteer Inclusion Criteria: 1. No history of chronic skin conditions 2. No recent history of antibiotic use Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
Contact & Investigator
Haley B Naik, MD, MHSc, FAAD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT03967600 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Hidradenitis Suppurativa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03967600 currently recruiting?
Yes, NCT03967600 is actively recruiting participants. Contact the research team at Kaelin.Chatterley@ucsf.edu for enrollment information.
Where is the NCT03967600 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT03967600 clinical trial?
NCT03967600 is sponsored by University of California, San Francisco. The principal investigator is Haley B Naik, MD, MHSc, FAAD at University of California, San Francisco. The trial plans to enroll 1,000 participants.